TY - JOUR
T1 - A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents
T2 - A Cluster-Controlled Intervention Study
AU - Berg, Anna Korsgaard
AU - Grauslund, Annemarie Cecilie
AU - Sørensen, Fiona
AU - Thorsen, Steffen Ullitz
AU - Thyssen, Jacob P
AU - Zachariae, Claus
AU - Svensson, Jannet
N1 - © 2023 by the American Diabetes Association.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - OBJECTIVE: Diabetes devices that deliver insulin and measure blood glucose levels are cornerstones in modern treatment of type 1 diabetes. However, their use is frequently associated with the development of skin problems, particularly eczema and wounds. Proper skin care may prevent skin problems, yet evidence-based information from interventional studies is missing. Providing this information is the aim of this study.RESEARCH DESIGN AND METHODS: This cluster-controlled intervention study tested the efficacy of a basic skin care program (including use of lipid cream, removal, and avoidance of disinfection). A total of 170 children and adolescents with type 1 diabetes were included and assigned either to the intervention group (n = 112) or the control group (n = 58). Participants were seen quarterly the first year after device initiation, with clinical assessment and interview in an unblinded setting.RESULTS: Eczema or wounds were observed in 33.6% of the intervention group compared with 46.6% of control participants (absolute difference, 12.9% [95% CI -28.7%, 2.9%]; P = 0.10). The adjusted odds of wound development were decreased by 71% in the intervention compared with control group (for wounds, odds ratio 0.29 [95% CI 0.12, 0.68]; P = 0.005). In total, only eight infections were seen, without a higher frequency in the intervention group, despite advice to omit disinfection.CONCLUSIONS: These data indicate our basic skin care program partially prevented diabetes device-induced skin reactions. However, more preventive strategies with other adhesives, patches, and/or types of lotions are needed for optimized prevention.
AB - OBJECTIVE: Diabetes devices that deliver insulin and measure blood glucose levels are cornerstones in modern treatment of type 1 diabetes. However, their use is frequently associated with the development of skin problems, particularly eczema and wounds. Proper skin care may prevent skin problems, yet evidence-based information from interventional studies is missing. Providing this information is the aim of this study.RESEARCH DESIGN AND METHODS: This cluster-controlled intervention study tested the efficacy of a basic skin care program (including use of lipid cream, removal, and avoidance of disinfection). A total of 170 children and adolescents with type 1 diabetes were included and assigned either to the intervention group (n = 112) or the control group (n = 58). Participants were seen quarterly the first year after device initiation, with clinical assessment and interview in an unblinded setting.RESULTS: Eczema or wounds were observed in 33.6% of the intervention group compared with 46.6% of control participants (absolute difference, 12.9% [95% CI -28.7%, 2.9%]; P = 0.10). The adjusted odds of wound development were decreased by 71% in the intervention compared with control group (for wounds, odds ratio 0.29 [95% CI 0.12, 0.68]; P = 0.005). In total, only eight infections were seen, without a higher frequency in the intervention group, despite advice to omit disinfection.CONCLUSIONS: These data indicate our basic skin care program partially prevented diabetes device-induced skin reactions. However, more preventive strategies with other adhesives, patches, and/or types of lotions are needed for optimized prevention.
KW - Adolescent
KW - Child
KW - Diabetes Mellitus, Type 1/therapy
KW - Eczema/prevention & control
KW - Humans
KW - Insulin/therapeutic use
KW - Research Design
KW - Skin Care
UR - http://www.scopus.com/inward/record.url?scp=85175193116&partnerID=8YFLogxK
U2 - 10.2337/dc23-0462
DO - 10.2337/dc23-0462
M3 - Journal article
C2 - 37478335
SN - 1935-5548
VL - 46
SP - 1770
EP - 1777
JO - Diabetes Care
JF - Diabetes Care
IS - 10
ER -